Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

191
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
191
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

209
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
209
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

251
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
251

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Dysregulated Metabolism in People Living With HIV in the Modern ART-Era: A Systematic Review of Targeted Metabolomics Studies.

Reviews in medical virology·2026
Same author

Insights from LC-MS-based cerebrospinal fluid metabolomics in tuberculous meningitis.

Frontiers in molecular biosciences·2026
Same author

Metabolomics of HIV in the Modern cART Era.

Advances in experimental medicine and biology·2026
Same author

Future perspectives on the use of molecular assays for pathogen identification in neonatal sepsis: a survey study among members of the European Society for Paediatric Infectious Diseases.

BMJ paediatrics open·2026
Same author

Comparative metabolic profiling of pediatric cerebrospinal fluid reveals disease-specific biomarkers in HIV and TB meningitis.

Scientific reports·2026
Same author

Rare Severe Complications of a Group A Streptococcal Infection in a Young Child: A Case Report.

The Pediatric infectious disease journal·2026

相关实验视频

Updated: Jan 14, 2026

Absolute Quantification of Aβ1-42 in CSF Using a Mass Spectrometric Reference Measurement Procedure
08:40

Absolute Quantification of Aβ1-42 in CSF Using a Mass Spectrometric Reference Measurement Procedure

Published on: March 21, 2017

8.0K

儿科CSF的乙卡尼丁基准范围范围

Ontefetse Neo Plaatjie1, A Marceline Tutu Van Furth1,2, Regan Solomons3

  • 1Department of Biochemistry, Biomedical and Molecular Metabolism Research, Faculty of Natural and Agricultural Sciences, North-West University, Potchefstroom, South Africa.

Frontiers in molecular biosciences
|October 17, 2025
PubMed
概括

这项研究确定了儿童脑脊液 (CSF) 乙卡尼丁水平的关键参考范围. 这些发现有助于理解儿科中枢神经系统 (CNS) 疾病和甲酸代谢.

关键词:
乙卡尼丁酸盐是一种大脑脊髓液 (CSF) 是一种孩子们的孩子们的孩子们的孩子们.儿科 儿科医生 儿科参考范围的参考范围.

更多相关视频

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status
07:08

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status

Published on: October 20, 2016

8.2K
An Improved Method for Collection of Cerebrospinal Fluid from Anesthetized Mice
06:40

An Improved Method for Collection of Cerebrospinal Fluid from Anesthetized Mice

Published on: March 19, 2018

66.1K

相关实验视频

Last Updated: Jan 14, 2026

Absolute Quantification of Aβ1-42 in CSF Using a Mass Spectrometric Reference Measurement Procedure
08:40

Absolute Quantification of Aβ1-42 in CSF Using a Mass Spectrometric Reference Measurement Procedure

Published on: March 21, 2017

8.0K
A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status
07:08

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status

Published on: October 20, 2016

8.2K
An Improved Method for Collection of Cerebrospinal Fluid from Anesthetized Mice
06:40

An Improved Method for Collection of Cerebrospinal Fluid from Anesthetized Mice

Published on: March 19, 2018

66.1K

科学领域:

  • 生物化学 生物化学
  • 神经科学是一个神经科学.
  • 儿科 儿科 儿科

背景情况:

  • 乙卡尼丁对能量代谢至关重要,特别是脂肪酸β-氧化和脑脂质合成.
  • 血和脑脊液中的阿基尔卡尼丁水平变化与中枢神经系统 (CNS) 疾病有关.
  • 目前的CSF乙基卡尼丁研究主要集中在成年人身上,留下了儿科数据缺口.

研究的目的:

  • 为了在儿科队列中确定CSF度的正常参考范围.
  • 为了解决缺乏用于CSF乙卡尼丁分析的儿科特异性数据的问题.
  • 为研究小儿中枢神经系统疾病中的乙卡尼丁提供基础.

主要方法:

  • 液体染色学-双重质谱法 (LC-MS/MS) 用于甲胺的分析.
  • 从没有脑膜炎的57名儿童收集了脑脊髓液样本.
  • 进行了对各种乙卡尼丁物种的定量分析.

主要成果:

  • 在非脑膜炎的儿童中建立了CSF度的参考范围.
  • 报告的度范围从0.01微米到4.21微米.
  • 提供了对儿科CSF乙卡尼丁的第一个全面数据集.

结论:

  • 该研究成功生成了儿科CSF乙卡尼丁的基本参考范围.
  • 这些发现对于诊断和理解儿科中枢神经系统疾病至关重要.
  • 这项研究弥合了儿科神经代谢方面的重大知识差距.